Skip to content

Hearing · house

Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.

2026-07-15 · 14:15

Source status: Scheduled

Committee

Location

2123, Rayburn House Office Building

Video

Witnesses

  1. Dr. Cynthia Verst

    President, Design and Delivery Innovation, R&D Solutions, IQVIA

  2. Ms. Susan Winckler

    CEO, Reagan-Udall Foundation for the FDA

  3. Dr. Aaron Kowalski

    CEO, Breakthrough T1D

  4. Dr. Thomas Hwang

    Assistant Professor of Medicine, Brigham and Women's Hospital and Harvard Medical School

  5. Mr. Thomas Bollyky

    Bloomberg Chair in Global Health, Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, Council

Documents

Source: https://api.congress.gov/v3/committee-meeting/119/house/119457